Hexagon Capital Partners LLC Cuts Position in CME Group Inc. (NASDAQ:CME)

Hexagon Capital Partners LLC trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 14.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,852 shares of the financial services provider’s stock after selling 303 shares during the period. Hexagon Capital Partners LLC’s holdings in CME Group were worth $409,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. BOKF NA grew its position in CME Group by 0.3% during the 4th quarter. BOKF NA now owns 31,695 shares of the financial services provider’s stock valued at $6,675,000 after purchasing an additional 97 shares during the last quarter. Ethic Inc. raised its holdings in CME Group by 7.2% in the 4th quarter. Ethic Inc. now owns 40,140 shares of the financial services provider’s stock worth $8,453,000 after acquiring an additional 2,688 shares during the last quarter. Power Corp of Canada bought a new position in CME Group in the 4th quarter valued at approximately $3,223,000. Clear Street Markets LLC purchased a new stake in CME Group during the 4th quarter valued at $1,137,000. Finally, Groupama Asset Managment bought a new stake in shares of CME Group in the 4th quarter worth $25,282,000. 87.75% of the stock is owned by institutional investors.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Down 0.1 %

Shares of NASDAQ:CME opened at $221.46 on Thursday. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $226.78. The company has a market cap of $79.74 billion, a PE ratio of 25.19, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. The stock has a 50 day moving average of $213.12 and a 200 day moving average of $207.73. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the prior year, the company posted $2.30 earnings per share. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. As a group, equities research analysts expect that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 52.33%.

Analysts Set New Price Targets

Several equities research analysts recently commented on CME shares. Bank of America increased their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Citigroup lifted their price target on shares of CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Barclays increased their price objective on shares of CME Group from $209.00 to $219.00 and gave the company an “equal weight” rating in a research report on Monday. TD Cowen started coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price target on shares of CME Group in a report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $217.71.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.